US 12195535
Antibodies binding to VISTA at acidic pH
granted A61KA61K39/39591A61P
Quick answer
US patent 12195535 (Antibodies binding to VISTA at acidic pH) held by Five Prime Therapeutics, Inc. expires Mon Jan 09 2045 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Five Prime Therapeutics, Inc.
- Grant date
- Tue Jan 14 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jan 09 2045 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 37
- CPC classes
- A61K, A61K39/39591, A61P, A61P31/12, A61P35/00